Adma Biologics Inc Earnings

Adma Biologics Inc’s revenue jumped 59.06% since last year same period to $117.55Mn in the Q4 2024. On a quarterly growth basis, Adma Biologics Inc has generated -1.91% fall in its revenue since last 3-months.

Adma Biologics Inc’s net profit jumped 734.17% since last year same period to $111.9Mn in the Q4 2024. On a quarterly growth basis, Adma Biologics Inc has generated 211.61% jump in its net profits since last 3-months.

Adma Biologics Inc’s net profit margin jumped 498.7% since last year same period to 95.19% in the Q4 2024. On a quarterly growth basis, Adma Biologics Inc has generated 217.68% jump in its net profit margins since last 3-months.

Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a 1.17% jump from last quarter’s estimates.

Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.15.

Adma Biologics Inc’s earning per share (EPS) jumped 270% since last year same period to 0.14 in the Q4 2024. This indicates that the Adma Biologics Inc has generated 270% annual rate of jump in its earning per share (EPS) in the last 4 quarters.